Assessment of coregistration and agreement of the T2 FLAIR-and RD-based abnormality masks. Here we see 3 examples of the subject's native space (left column) and Montreal Neurological Institute space (middle row) T2 FLAIR lesion masks. We also overlay the RD-based lesion masks in blue for comparison with the T2 FLAIR lesion masks. Because the image resolution and brain orientations are not identical across the different modalities/orientations, it is difficult to compare the locations directly on a section-by-section basis. However, we see that the Montreal Neurological Institute space masks respect the ventricular boundary and generally appear to be indicating the same general anatomic location. We also see that in most cases, the RD-based masks are either circumscribed by or in close proximity to the T2-FLAIR lesion masks. These locations increase confidence that our coregistration and lesion-creation algorithms are adequate.
The performance of the PLSR model with respect to generalizability to the rest of the population was assessed using leave-one-out or jackknife cross-validation. 1 More specifically, we removed 1 subject from the data and observation and calculated the PLSR model for a given number of components on the remaining data. We then calculated the prediction error for the data point that was removed and calculated the error, repeating this until all of the data points had been removed. The Predicted Residual Sum of Squares (PRESS) 2 for the model with that number of components was then the sum of all of the errors. One issue particular to PLSR is to how to choose the correct number of components to be included in the final model so that prediction is optimized without fitting noise (ie, overfitting). One way to do this is to observe the value of PRESS as you add components. Initially the value of PRESS decreases as the model includes more information about the data and the prediction becomes more accurate. As noise begins to affect model estimation, PRESS increases because the generalizability of each model decreases. Therefore, we chose the number of components for each model to be the value at which adding 1 more component caused an increase in PRESS.
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After we chose the number of components in the model, bootstrapping (resampling the data with replacement) 4 was used to assess the effect of population variation on the final results and to get a measure of stability for each of the regression coefficients. Bootstrapping in a population of this size is especially important to assess the effect of the particular characteristics of the population on the final model so that it has better generalizability to the whole population. Confidence intervals for the regression coefficients and the R 2 of the model fit were calculated using the biascorrected and accelerated percentile method. 5 Confidence intervals were calculated to perform a hypothesis test-in this case, to test whether a regression coefficient was nonzero. A hypothesis test was performed for each of the 173 input variables (ChaCo in 86 brain regions, atrophy in 86 brain regions, and age) in each of the 2 WM biomarker-based models; the Šidák method 6 was used to correct for all tests. If the confidence interval of the regression coefficient of a particular variable did not include zero, then it was considered a significant predictor of the SDMT.
ON-LINE APPENDIX B: VARIABILITY OF ChaCo SCORES
Some aspects of the reliability and validity of the ChaCo measure have been explored in our article that introduced the NeMo Tool (see the on-line supplemental information in Kuceyeski et al 7 ). In that work, it was shown that the reliability of the scores evaluated in the space of the original tractography versus common Montreal Neurological Institute space was very high: ChaCo scores evaluated in native space versus Montreal Neurological Institute space had a Pearson correlation of 0.95. In addition, we removed certain well-known WM regions and calculated their ChaCo scores to show that the results were what we expected on the basis of normal anatomy.
However, the location and topology of WM tracts vary from individual to individual. Therefore, the impact of a given WM abnormality may also vary from individual to individual. The NeMo tool attempts to capture this variability by calculating the impact of WM abnormality across 73 healthy controls and reporting the average. This idea is not a new one: Any atlas-based method makes the same assumptions. It is important, however, to inspect the level of variability across healthy controls to get an idea of the confidence that can be assigned to the final ChaCo scores. Therefore, we calculated a measure of dispersion (ie, the quartile coefficient of dispersion (Q 3 Ϫ Q 2 )/(Q 3 ϩ Q 2 ) where Q i is the i th percentile) of the T2 FLAIR-based ChaCo scores across healthy controls. On-line Fig 4 gives the distribution of dispersion measures over the 121 subjects with MS for each GM region. Values that are larger correspond to those regions that had greater dispersion in the healthy population and thus may correspond to less reliable ChaCo scores. In this figure, we only included regions with Ͼ1% of tracts disrupted (ChaCo Ͻ Ϫ0.01) because the dispersion measure is unreliable for values close to zero. Those regions with relatively high dispersion, such as the entorhinal and parahippocampal regions, were areas that, in general, were not important in our analysis. 
ON-LINE FIG 1.
Barplots of ChaCo scores and atrophy. These barplots illustrate the distributions of ChaCo scores (left 2 columns) and atrophy (right column) over the population of 121 subjects with MS for each of the 86 GM regions considered. The ChaCo score plots are color-coded by the imaging modality that was used to produce the abnormality masks. Cyan indicates axial diffusivity maps; blue, fractional anisotropy maps; green, mean diffusivity maps; black, radial diffusivity maps; and red, T2 FLAIR hyperintensities.
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